However, PIP within the TGN has also been suggested to recruit NLRP3, leading to NLRP3 aggregation and downstream inflammatory signalling [529], with inhibition of NLRP3 improving MASLD pathology and fibrosis in obese diabetic mice [530]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.